HomeProductsAGP PharmaCeclor Mr Bd Tablets 375Mg

Ceclor Mr Bd Tablets 375Mg

 650

Add to wishlist
Share
Category

    Ceclor MR BD Tablets 375 mg

    Composition:

    • Active Ingredient: Cefaclor (375 mg)

    Formulation:

    • Extended-release formulation (MR – Modified Release)

    Indications:

    • Used for the treatment of bacterial infections, including:
      • Respiratory tract infections
      • Skin and soft tissue infections
      • Urinary tract infections
      • Otitis media (middle ear infections)

    Mechanism of Action:

    • Cefaclor is a cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.

    Dosage:

    • Typical dosage for adults and children (based on the specific infection) may vary.
    • Commonly prescribed as 375 mg taken every 8-12 hours.
    • Follow the healthcare provider’s instructions for specific dosing.

    Side Effects:

    • Common Side Effects: Nausea, vomiting, diarrhea, abdominal pain, and rash.
    • Serious Side Effects: Allergic reactions (anaphylaxis), severe gastrointestinal effects (such as pseudomembranous colitis), and liver enzyme elevations.

    Contraindications:

    • Known hypersensitivity to cefaclor or other cephalosporins.
    • Caution in patients with a history of penicillin allergy.

    Storage:

    • Store at room temperature, away from moisture and direct sunlight.

    Precautions:

    • Monitor for signs of allergic reactions.
    • Assess renal function before and during treatment, as dosage adjustments may be necessary for patients with renal impairment.

    Patient Counseling:

    • Complete the full course of antibiotics as prescribed, even if symptoms improve.
    • Take with food to reduce gastrointestinal side effects.

    For any specific concerns or detailed instructions, consulting a healthcare professional is always recommended.

    Reviews

    There are no reviews yet.

    Be the first to review “Ceclor Mr Bd Tablets 375Mg”

    Your email address will not be published. Required fields are marked *